About us

From bedside to Brussels: hematology at the forefront of EU health policy

Access is at the heart of EHA's European Affairs work. More specifically, equitable and affordable access to innovative therapies that are of clear added benefit from a clinical, patient, and public health perspective.

Collaboration with the EMA on Joint Clinical Assessments and Joint Scientific Consultations under the HTA Regulation

The European Hematology Association (EHA) welcomes the draft Implementing Act laying down procedural rules for the exchange of information between the Health Technology Assessment (HTA) Coordination Group, the European Commission, and the European Medicines Agency (EMA).

Young National Society Ambassadors

Early-career ambassadors from national societies who liaise with EHA and the Young EHA Committee on different projects.

The European Health Data Space Regulation is a reality

The European Health Data Space (EHDS) Regulation has made it to the EU’s Official Journal, almost three years after the initial proposal was published.

The new EU clinical trials map is online

A new clinical trial map was launched by EMA as part of the Clinical Trials Information System (CTIS) on March 3.